Sphincter of Oddi dysfunction: Cut and inject, but don't measure the pressure?

Endoscopy

Volumn 36, Issue 2, 2004, Pages 179-182

  Wehrmann, T ^a  

^a Hanover Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; NITRO DERIVATIVE; PANCREAS ENZYME;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFECT; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPIGASTRIC PAIN; FOLLOW UP; HUMAN; LONG TERM CARE; MANOMETRY; ODDI SPHINCTER; PANCREATITIS; PRIORITY JOURNAL; SPHINCTEROTOMY; VATER PAPILLA STENOSIS;

ACUTE DISEASE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COMMON BILE DUCT DISEASES; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; MANOMETRY; PANCREATITIS; PRESSURE; SPHINCTER OF ODDI; SPHINCTEROTOMY, ENDOSCOPIC;

EID: 0842346829     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814187     Document Type: Editorial

References (39)

1. Wehrmann T, Seifert H, Hagenmüller F et al. Endoscopic sphincter of Oddi manometry - Does skepticism vanish? Z Gastroenterol 1996; 34: 17-25
2. Allescher HD. Clinical impact of sphincter of Oddi dyskinesia. Endoscopy 1998; 30 (Suppl 2): 231-236
3. Tzovaras G, Rowlands BJ. Diagnosis and treatment of sphincter of Oddi dysfunction. Br J Surg 1998; 85: 588-595
4. Wehrmann T, Stergiou N, Riphaus A, Lembcke B. Correlation between sphincter of Oddi manometry and intraductal ultrasound morphology in patients with suspected sphincter of Oddi dysfunction. Endoscopy 2001; 33: 773-777
5. Guelrud M, Mendoza S, Rossiter G, Villegas MI. Sphincter of Oddi manometry in healthy volunteers. Dig Dis Sci 1990; 35: 38-46
6. Lans JL, Parikh NP, Greenen JE. Application of sphincter of Oddi manometry in routine clinical investigations. Endoscopy 1991; 23: 139-143
7. Rolny P, Geenen JE, Hogan W. Post-cholecystectomy patients with objective signs of partial bile outflow obstruction: Clinical characteristics, sphincter of Oddi manometry findings, and results of therapy. Gastrointest Endosc 1993; 39: 778-781
8. Wehrmann T, Wiemer K, Lembcke B, Jung M. Effect of endoscopic sphincterotomy on sphincter of Oddi manometry results in patients with or without papillary stenosis. Z Gastroenterol 1995; 33: 662-668
9. American Motility Society. Position paper: Sphincter of Oddi manometry. Gastrointest Endosc 1997; 45: 342-348
10. Ladas SD, Tassios PS, Katsogridakis J et al. The clinical need for sphincter of Oddi manometry in gastrointestinal endoscopy units. Endoscopy 1993; 25: 387-391
11. Geenen JE, Hogan WJ, Dodds WJ et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction. N Engl J Med 1989; 320: 82-87
12. Toouli J, Roberts-Thomson IC, Kellow J et al. Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 2000; 46: 98-102
13. Botoman VA, Kozarek RA, Novell LA et al. Long term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction. Gastrointest Endosc 1994; 40: 165-170
14. Bozkurt T, Orth KH, Butsch B, Lux G. Long term clinical outcome of post-cholecystectomy patients with biliary type pain: Results of manometry, non-invasive techniques and endoscopic sphincterotomy. Eur J Gastroenterol Hepatol 1996; 8: 245-249
15. Wehrmann T, Wiemer K, Lembcke B et al. Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A five year prospective trial. Eur J Gastroenterol Hepatol 1996; 8: 251-256
16. Chen JWC, Saccone GTP, Toouli J. Sphincter of Oddi dysfunction and acute pancreatitis. Gut 1998; 43: 305-308
17. Geenen JE, Nash JA. The role of sphincter of Oddi manometry and biliary microscopy in evaluating idiopathic recurrent pancreatitis. Endoscopy 1998; 30 (Suppl 2): 237-241
18. Guelrud M, Plaz J, Mendoza S et al. Endoscopic treatment of type II pancreatic sphincter dysfunction [abstract]. Gastrointest Endosc 1995; 41: 398
19. Lehman GA, Sherman S. Hypertensive pancreatic sphincter. Can J Gastroenterol 1998; 12: 333-337
20. Wehrmann T, Zipf A, Caspary WF, Jung M. Sphincter of Oddi dysfunction in patients with idiopathic recurrent pancreatitis. Dtsch Med Wochenschr 1996; 121: 781-787
21. Gorelick A, Barnett J, Chey W et al. Botulinum toxin after biliary sphincterotomy. Endoscopy 2004; 35: 170-173
22. Pasricha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 1994; 35: 1319-1321
23. Muehldorfer SM, Hahn EG, Ell C. Botulinum toxin as a diagnostic tool of verification of sphincter of Oddi dysfunction causing recurrent pancreatitis. Endoscopy 1997; 29: 120-124
24. Wehrmann T, Seifert H, Seipp M, Lembcke B, Caspary WF. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 1998; 30: 702-707
25. Wehrmann T, Schmitt T, Arndt A et al. Endoscopic botulinum toxin injection for treatment of idiopathic recurrent pancreatitis due to sphincter of Oddi dysfunction. Aliment Pharmacol Ther 2000; 14: 1469-1477
26. Tarnasky P, Cunningham J, Cotton P et al. Pancreatic sphincter hypertension increases the risk of post ERCP-pancreatitis. Endoscopy 1997; 29: 252-257
27. Eversman D, Fogel EL, Rusche M et al. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc 1999; 50: 637-641
28. Tarnasky PR, Palesch YY, Cunningham JT et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115: 1518-1524
29. Okolo PI, Wadwa K, Magee CA et al. Immediate reduction of pancreatic SO pressure after endoscopic injection of botulinum toxin (BoTox): Implications for prevention of ERCP-induced pancreatitis [abstract]. Gastroenterology 1998; 114: A535
30. Marksk JM, Bower AL, Goormastic M et al. A comparison of common bile duct pressures after botulinum toxin injection into the sphincter of Oddi versus biliary stenting in a canine model. Am J Surg 2001; 181: 60-64
31. MacKenzie J, Burnstock J, Dolly JO. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropin-resistant autonomic neuromuscular transmission. Neuroscience 1982; 7: 997-1006
32. Montecucco C, Schiavo G. Mechanisms of action of tetanus and botulinum neurotoxins. Molec Microbiol 1994; 13: 1-8
33. James AN, Ryan JP, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol 2003; 285: G291-G297
34. Luman W, Pryde A, Heading RC, Palmer KR. Topical glyceryl trinitrate relaxes the sphincter of Oddi. Gut 1997; 40: 541-543
35. Wehrmann T, Schmitt T, Stergiou N et al. Topical application of nitrates onto the papilla of Vater: Manometric and clinical results. Endoscopy 2001; 33: 323-328
36. Sudhindran S, Bromwich E, Edwards PR. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001; 88: 1178-1182
37. Gorelick AB, Barnett JL, Chey WD et al. A study of botulinum toxin injection into the residual pancreatic sphincter after biliary sphincterotomy in patients with sphincter of Oddi dysfunction [abstract]. Gastrointest Endosc 2001; 53: AB94
38. Arguedas MR, Linder JD, Wilcox CM. Suspected sphincter of Oddi dysfunction type II: Empiric biliary sphincterotomy or manometric-guided therapy. Endoscopy 2004; 35: 174-178
39. Lin OS, Soetinho RM, Young HS. The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction. Am J Gastroenterol 1998; 93: 1833-1836